One of the most ubiquitous pieces of ad tech is under the scrutiny of federal regulators.
The FTC recently published a deep dive into pixels and their potential risks to consumers, noting that “companies using tracking pixels that impermissibly disclose an individual’s personal information (which may include health information) to third parties” may be in violation of a host of state and federal laws.
The explainer came after the regulatory body slapped fines on discount drug provider GoodRx in February and digital therapy firm BetterHelp earlier this month, for $1.5
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in